NATURE’S SUNSHINE PRODUCTS, INC. Stockholders' Equity Attributable to Noncontrolling Interest
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-03-10
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $6.20M.
- 2025-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $6.00M.
- 2025-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $5.82M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | $6.20M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.00M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $5.82M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $5.68M 10-K · filed 2026-03-10 |
| 2024-09-30 | $6.09M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.79M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.65M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $5.48M 10-K · filed 2025-03-11 |
| 2023-09-30 | $5.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $4.79M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.54M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $4.14M 10-K · filed 2024-03-12 |
| 2022-09-30 | $4.01M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.90M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.47M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.20M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.84M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.24M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.85M 10-K · filed 2022-03-08 |
| 2020-09-30 | $1.06M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $650.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $271.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $227.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $9.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$25.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $35.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $63.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | -$41.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $117.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $246.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $411.00K 10-K · filed 2019-03-08 |
| 2017-09-30 | $661.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $756.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $989.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.29M 10-K · filed 2018-03-16 |
| 2016-09-30 | $2.06M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.27M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.47M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $2.75M 10-K · filed 2017-03-14 |
| 2015-09-30 | $3.11M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $3.46M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $3.63M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $3.78M 10-K · filed 2016-03-14 |
| 2014-09-30 | $3.97M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |